» Articles » PMID: 28549061

Central Hypothyroidism - a Neglected Thyroid Disorder

Overview
Specialty Endocrinology
Date 2017 May 27
PMID 28549061
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Central hypothyroidism is a rare and heterogeneous disorder that is characterized by a defect in thyroid hormone secretion in an otherwise normal thyroid gland due to insufficient stimulation by TSH. The disease results from the abnormal function of the pituitary gland, the hypothalamus, or both. Moreover, central hypothyroidism can be isolated or combined with other pituitary hormone deficiencies, which are mostly acquired and are rarely congenital. The clinical manifestations of central hypothyroidism are usually milder than those observed in primary hypothyroidism. Obtaining a positive diagnosis for central hypothyroidism can be difficult from both a clinical and a biochemical perspective. The diagnosis of central hypothyroidism is based on low circulating levels of free T in the presence of low to normal TSH concentrations. The correct diagnosis of both acquired (also termed sporadic) and congenital (also termed genetic) central hypothyroidism can be hindered by methodological interference in free T or TSH measurements; routine utilization of total T or T measurements; concurrent systemic illness that is characterized by low levels of free T and normal TSH concentrations; the use of the sole TSH-reflex strategy, which is the measurement of the sole level of TSH, without free T, if levels of TSH are in the normal range; and the diagnosis of congenital hypothyroidism based on TSH analysis without the concomitant measurement of serum levels of T. In this Review, we discuss current knowledge of the causes of central hypothyroidism, emphasizing possible pitfalls in the diagnosis and treatment of this disorder.

Citing Articles

Central Hypothyroidism with Low TSH Compared to Normal TSH Is Associated with More Advanced Pituitary Disease and Less Favorable Metabolic Profile.

Matusiak A, Stepniak J, Lewandowski K, Lewinski A, Karbownik-Lewinska M Metabolites. 2025; 15(2).

PMID: 39997750 PMC: 11857551. DOI: 10.3390/metabo15020125.


An Update on Advances in Hypopituitarism: Etiology, Diagnosis, and Current Management.

Iglesias P J Clin Med. 2024; 13(20).

PMID: 39458112 PMC: 11508259. DOI: 10.3390/jcm13206161.


Prevalence of thyroid disorders among the diabetic population in Arar, Saudi Arabia.

Elmisbah H, Laham R, Almisbah H, Alanazi H, Alanazi T, Alanzi R Saudi Med J. 2024; 45(6):591-597.

PMID: 38830661 PMC: 11147588. DOI: 10.15537/smj.2024.45.6.20240144.


Commentary: Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma.

Andereggen L, Christ E Front Endocrinol (Lausanne). 2024; 15:1371424.

PMID: 38476669 PMC: 10928441. DOI: 10.3389/fendo.2024.1371424.


Genetic Basis of Congenital Central Hypothyroidism in Children: Expanding the Mutational Spectrum of POU1F1 and ATP6V0A4.

Fu C, Luo J, Su J, Zhang S, Yang Q, Zhang Y Int J Gen Med. 2023; 16:3355-3362.

PMID: 37576911 PMC: 10422988. DOI: 10.2147/IJGM.S421382.


References
1.
Persani L, Borgato S, Romoli R, Asteria C, Pizzocaro A, Beck-Peccoz P . Changes in the degree of sialylation of carbohydrate chains modify the biological properties of circulating thyrotropin isoforms in various physiological and pathological states. J Clin Endocrinol Metab. 1998; 83(7):2486-92. DOI: 10.1210/jcem.83.7.4970. View

2.
Wiersinga W . Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism. Nat Rev Endocrinol. 2014; 10(3):164-74. DOI: 10.1038/nrendo.2013.258. View

3.
LaFranchi S . Newborn screening strategies for congenital hypothyroidism: an update. J Inherit Metab Dis. 2010; 33(Suppl 2):S225-33. DOI: 10.1007/s10545-010-9062-1. View

4.
Ferretti E, Persani L, Jaffrain-Rea M, Giambona S, Tamburrano G, Beck-Peccoz P . Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab. 1999; 84(3):924-9. DOI: 10.1210/jcem.84.3.5553. View

5.
Gamberini M, De Sanctis V, Gilli G . Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. Pediatr Endocrinol Rev. 2009; 6 Suppl 1:158-69. View